U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H16ClN3O
Molecular Weight 277.749
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ELB-139

SMILES

ClC1=CC=C(C=C1)N2CC(=NC2=O)N3CCCCC3

InChI

InChIKey=YGXIELIREXEJQN-UHFFFAOYSA-N
InChI=1S/C14H16ClN3O/c15-11-4-6-12(7-5-11)18-10-13(16-14(18)19)17-8-2-1-3-9-17/h4-7H,1-3,8-10H2

HIDE SMILES / InChI

Molecular Formula C14H16ClN3O
Molecular Weight 277.749
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Modifications of antiepileptic drugs for improved tolerability and efficacy.
2008 Feb 14
Patents

Patents

Substance Class Chemical
Created
by admin
on Sat Dec 16 06:40:06 UTC 2023
Edited
by admin
on Sat Dec 16 06:40:06 UTC 2023
Record UNII
BKP2A5554F
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ELB-139
Common Name English
1-(4-CHLOROPHENYL)-4-PIPERIDIN-1-YL-1,5-DIHYDRO-IMIDAZOL-2-ONE
Systematic Name English
LS-191811
Code English
LS-191,811
Code English
2H-IMIDAZOL-2-ONE, 1-(4-CHLOROPHENYL)-1,5-DIHYDRO-4-(1-PIPERIDINYL)-
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID40877536
Created by admin on Sat Dec 16 06:40:06 UTC 2023 , Edited by admin on Sat Dec 16 06:40:06 UTC 2023
PRIMARY
PUBCHEM
11277418
Created by admin on Sat Dec 16 06:40:06 UTC 2023 , Edited by admin on Sat Dec 16 06:40:06 UTC 2023
PRIMARY
CAS
188116-08-7
Created by admin on Sat Dec 16 06:40:06 UTC 2023 , Edited by admin on Sat Dec 16 06:40:06 UTC 2023
PRIMARY
WIKIPEDIA
ELB-139
Created by admin on Sat Dec 16 06:40:06 UTC 2023 , Edited by admin on Sat Dec 16 06:40:06 UTC 2023
PRIMARY
FDA UNII
BKP2A5554F
Created by admin on Sat Dec 16 06:40:06 UTC 2023 , Edited by admin on Sat Dec 16 06:40:06 UTC 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY